Idiopathic Inflammatory Myopathies

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000035" target="_blank" >RIV/00023728:_____/19:N0000035 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1016/S0889-857X(02)00096-0" target="_blank" >https://doi.org/10.1016/S0889-857X(02)00096-0</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.rdc.2019.07.006" target="_blank" >10.1016/j.rdc.2019.07.006</a>

Result language
angličtina
Original language name
Idiopathic Inflammatory Myopathies
Original language description
Major advances have been made in the field of idiopathic inflammatory myopathies (IIM), or myositis, that are likely to facilitate development of new therapeutic strategies that have not yet been applied in this group of diseases. These advances include new classification criteria to better identify the patients with IIM, detection of several new myositis-specific autoantibodies that facilitates subgrouping of patients into more specific clinical phenotypes, development of outcome measures for disease activity, and new response criteria. We have learned from clinical studies that exercise is an important part of treatment and that pharmacologic treatment should be combined with exercise.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30226 - Rheumatology

Project
<a href="/en/project/NV16-33746A" target="_blank" >NV16-33746A: Skeletal muscle metabolic abnormalities in patients with idiopathic inflammatory myopathies</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)